Compare CVS Health Corp (CVS) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Nuscale Power Corporation — how do they compare? CVS Health Corp trades at $85.76 (market cap $112.29B), while Nuscale Power Corporation trades at $7.43 (market cap $3.00B). The key difference: CVS Health Corp is far larger — about 37.4× Nuscale Power Corporation's market cap, and CVS Health Corp pays a 3.03% dividend while Nuscale Power Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Nuscale Power Corporation for 29 Days on average.
| CVS | SMR | |
|---|---|---|
Market Cap | $112.29B | $3.00B |
Volume | 7,763,676 | 43,143,109 |
Sector | Health | Industrials |
52-Week High | $110.60 | $53.43 |
52-Week Low | $70.08 | $7.32 |
Typical Hold Time | 83 Days | 29 Days |
Enterprise Value | $174.64B | $1.93B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
NuScale Power (SMR) trades at $7.67, down 4.42% today, reflecting ongoing investor concerns about the company's financial performance. The stock shows bearish technical signals with negative moving averages and oscillators, while fundamentally the company faces significant challenges with a net income margin of -3,888.7% and negative cash flow from operations of $459.61 million in 2025. Recent news highlights both the nuclear industry's growth potential and specific challenges facing NuScale, including ongoing legal investigations.
Despite analyst consensus pointing to potential upside with a $11.25 price target, SMR faces substantial execution risks as it burns cash while pursuing commercialization. The company's ability to secure additional financing and achieve revenue growth will be critical for survival, making this a high-risk investment suitable only for investors comfortable with speculative nuclear technology plays.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
